These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25809122)

  • 1. Cerebrospinal fluid proteomics in children during induction for acute lymphoblastic leukemia: A pilot study.
    Priola GM; Foster MW; Deal AM; Richardson BM; Thompson JW; Blatt J
    Pediatr Blood Cancer; 2015 Jul; 62(7):1190-4. PubMed ID: 25809122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between cerebrospinal fluid osteopontin level and central nervous system involvement in childhood acute leukemia.
    Incesoy-Özdemir S; Sahin G; Bozkurt C; Oren AC; Balkaya E; Ertem U
    Turk J Pediatr; 2013; 55(1):42-9. PubMed ID: 23692831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
    Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
    Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
    Gassas A; Krueger J; Alvi S; Sung L; Hitzler J; Lieberman L
    Pediatr Blood Cancer; 2014 Dec; 61(12):2215-7. PubMed ID: 25212396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
    Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
    Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level of tau protein in children treated for acute lymphoblastic leukemia.
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
    Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid asparagine concentrations after Escherichia coli asparaginase in children with acute lymphoblastic leukemia.
    Woo MH; Hak LJ; Storm MC; Gajjar AJ; Sandlund JT; Harrison PL; Wang B; Pui CH; Relling MV
    J Clin Oncol; 1999 May; 17(5):1568-73. PubMed ID: 10334545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
    Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytological findings of the cerebrospinal fluid at diagnosis of acute lymphocytic leukemia in children--effect of remission induction chemotherapy].
    Kinumaki H; Bessho F; Yokota S
    Rinsho Ketsueki; 1989 Oct; 30(10):1763-8. PubMed ID: 2593242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity marker profiles in the CSF are not age-dependent but show variation in children treated for acute lymphoblastic leukemia.
    Van Gool SW; De Meyer G; Van de Voorde A; Vanmechelen E; Vanderstichele H
    Neurotoxicology; 2004 Mar; 25(3):471-80. PubMed ID: 15019310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.
    Ranta S; Nilsson F; Harila-Saari A; Saft L; Tani E; Söderhäll S; Porwit A; Hultdin M; Noren-Nyström U; Heyman M
    Pediatr Blood Cancer; 2015 Jun; 62(6):951-6. PubMed ID: 25545289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case series: CSF LDH, proteins and electrolyte levels in patients of acute lymphocytic leukemia.
    Rao D; Ghalaut VS; Ghalaut PS; Rao S
    Clin Chim Acta; 2012 Jul; 413(13-14):1045-8. PubMed ID: 22387722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
    Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
    Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
    Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
    Eisenkraft A; Keidan I; Bielorai B; Keller N; Toren A; Paret G
    Leuk Res; 2006 Oct; 30(10):1259-61. PubMed ID: 16516290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
    Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
    Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical diagnostic significance of cerebrospinal fluid detection with flow cytometry in children acute lymphoblastic leukemia accompanied by central nervous system leukemia].
    Yang WY; Wang HJ; Chen YM; Chen XJ; Zou Y; Guo Y; Wang SC; Liu TF; Zhu XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):38-42. PubMed ID: 22391161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse.
    Martínez-Laperche C; Gómez-García AM; Lassaletta Á; Moscardó C; Vivanco JL; Molina J; Fuster JL; Couselo JM; de Toledo JS; Bureo E; Madero L; Ramírez M
    Am J Hematol; 2013 May; 88(5):359-64. PubMed ID: 23468276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia.
    Rizzari C; Citterio M; Zucchetti M; Conter V; Chiesa R; Colombini A; Malguzzi S; Silvestri D; D'Incalci M
    Haematologica; 2006 Jan; 91(1):24-31. PubMed ID: 16434367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.